Ligand-directed protein labelling can be used to introduce diverse chemical functionalities onto proteins without the need for incorporation of genetically encoded tags. Here we report a method for the rapid and efficient labelling of a protein using a ruthenium-bipyridyl (Ru(II)(bpy)3) modified peptide designed to mimic an interacting BH3 ligand within a BCL-2 family protein-protein interaction (PPI). Using sub-stoichiometric quantities of (Ru(II)(bpy)3)-modified NOXA-B and irradiation with visible light for 1 minute, the anti-apoptotic protein MCL-1 was photolabelled in a ligand-dependent manner with a variety of functional tags, as determined by in-gel fluorescence, affinity purification, and ESI-MS analysis. In contrast with previous reports on Ru(II)(bpy)3-catalysed photolabelling, tandem MS experiments revealed that the dominant labelling occurred on a cysteine residue of MCL-1. Labelling of MCL-1 occurred selectively in mixtures with other proteins, including the structurally related BCL-2 member, BCL-xL. These results improve methodology for proximity-induced photolabelling of proteins, demonstrate the approach is applicable to interfaces that mediate PPIs, and pave the way towards future use of ligand-directed proximity labelling for dynamic analysis of the localisation and interactome of BCL-2 family proteins.
Introduction
Most cellular proteins function as dynamic complexes with other proteins and, conversely, protein-protein interactions (PPIs) play key roles in the regulation of most biological processes. 1 While stable PPIs are usually associated with multi-subunit protein complexes and quaternary structure, transient PPIs regulate multiple cellular processes, and are implicated in a variety of disease states. 2 Ongoing efforts to study transient PPIs may lead to better understanding of the processes of life and the development of novel diagnostics and therapeutics. As part of such efforts, the ability to selectively introduce chemical labels onto proteins involved in specific PPIs would provide new tools to study such PPIs, including the construction of protein-based biosensors or affinity enrichment reagents for dynamic interactome analysis.
Although numerous methods for chemical protein labelling exist, only few are suitable for the selective labelling of (subsets of) native proteins in complex biological samples, such as cell lysates, whole cells and tissues. 3 Many of these methods rely on enzymatic activity for the labelling of highly nucleophilic active site residues 4 or on the metabolic incorporation of non-natural substrates, such as amino acids, 5, 6 carbohydrates 7 and lipids, 8, 9 which can be further derivatised through bio-orthogonal chemistry. 5, 10, 11 An effective strategy that does not rely on enzymatic activity or post-translational modifications, and would therefore be especially suitable for the study of PPIs, is the use of liganddirected protein labelling (LDL). 12, 13 LDL relies on reagents consisting of a ligand for the protein-ofinterest attached to a (moderately) reactive chemical group (exchange/cleavage approach) or to a 
Results

Design and synthesis of reagents
The BH3 domain NOXA-B75-93(C75A) modified with an N-terminal FITC group (FITC-Ahx-AAQLRRIGDKVNLRQKLLN-CONH2; FITC-NOXA-B) retains its affinity for MCL-1, as determined by fluorescence anisotropy experiments. 44 Therefore, we designed an LDL reagent for the labelling of MCL-1 consisting of the same BH3 sequence linked to a Ru(II)(bpy)3 photocatalyst via an aminohexanoic acid (Ahx) linker on its N-terminus (Ru(II)(bpy)3-NOXA-B 1; Fig. 2a ). LDL reagent 1 was prepared through solid-phase peptide synthesis (Scheme S1-S2) and purified by preparative HPLC (Fig S1) . Recombinant MCL-1172-327 was expressed and purified as published previously. 44 Fluorescence anisotropy competition experiments -with FITC-NOXA-B as tracer -confirmed that 1 is a more potent inhibitor of the FITC-NOXA-B/MCL-1 interaction than the wild-type peptide Ac-NOXA-B 4 (as seen by a 10-fold reduction in IC50 value; Fig. 2b ), which could be the result of the hydrophobic nature of the bpy ligands or the additional charge of the Ru(II)(bpy)3 substituent of 1. Fluorescent (TAMRA-RTA 2) and biotinylated (biotin-RTA 3) radical trapping agents analogous to those developed by Nakamura and co-workers were synthesised through adaptation of literature procedures (Fig. 2a , Scheme S3).
Photocatalytic labelling of MCL-1
For photocatalytic LDL, Ru(II)(bpy)3-NOXA-B 1, TAMRA-RTA 2 and ammonium persulfate (APS) were added to a buffered solution of MCL-1 and the mixture was irradiated for 1 minute at 450 nm using blue LED lamps (see Supporting Information for details). An aqueous solution of the radical scavenger dithiothreitol (DTT, 10 mM) was then added to quench the reaction. 32 Optimisation of the labelling conditions resulted in fluorescent modification of MCL-1 using 20 mol% of peptide-catalyst 1 and an equimolar concentration (relative to [MCL-1]) of TAMRA-RTA 2 (lane 1, Fig. 2c ). Analysis of the labelled mixture using in-gel fluorescence indicated that ruthenium-modified peptide 1, fluorescent RTA 2 and visible light irradiation were all necessary for efficient labelling of MCL-1. A small amount of background labelling of MCL-1 occurred in the absence of 1, possibly due to the ability of the rhodamine dye in 2 to act as a photoredox catalyst 45, 46 (lane 3, Fig. 2c ; more clearly seen when larger amounts of protein were loaded onto the SDS-PAGE gel: Fig. S10-S12 ). This explanation is consistent with the absence of background labelling when biotin-RTA 3 was used instead of TAMRA-RTA 2 (see below and Fig. S17) . Furthermore, the addition of APS to the reaction mixture was necessary for efficient labelling of MCL-1 in these experiments, despite a small amount of labelling occurring when APS was omitted (lane 4, Fig. 2c ). In contrast to previous reports, 32,34,35 a substoichiometric amount of the Ru(II)(bpy)3 reagent (20 mol% relative to ) was used in these experiments, demonstrating the catalytic potential of this chemistry for protein labelling.
The identity of the labelled species was confirmed by intact protein electrospray ionisation mass spectrometry (ESI-MS). Prior to irradiation, only unmodified MCL-1 (17737 Da, Fig. 2d , left) could be detected in the reaction mixture. However, upon irradiation with visible light for 1 minute, the mass spectrum of the reaction mixture showed peaks corresponding to both unmodified MCL-1 (17737 Da) and the labelled species [(MCL-1) + 2] (18396 Da) (Fig. 2d, left) . These data confirm the main reaction product results from the addition of one TAMRA-RTA label, suggesting labelling of a single amino acid residue on MCL-1. Several additional peaks were evident in the MS trace of the irradiated sample (denoted by a star, Fig. 2d ), most likely resulting from the oxidation of amino acid residues on MCL-1 proximal to the Ru(II)(bpy)3 complex (indicated by several mass increases of +16 Da, see Fig. S19 ). Oxidation of proteins using Ru(II)(bpy)3 reagents in the absence of a 'radical trapper' has been reported previously, 30 and this has been exploited in chromophore-assisted light inactivation (CALI) 47,48 reagents that allow targeted protein inactivation with visible light, in vitro and in cells. 34, 36, 49, 50 Next, we investigated the labelling of MCL-1 using a different functional tag, biotin-RTA 3. ESI-MS analysis of the crude reaction mixture revealed the appearance of a distinct species (18209 Da, Fig. 2d , right) suggesting single biotin labelling of MCL-1 (for control experiments in the absence of individual reagents/conditions, see Fig S17) . The biotinylated MCL-1 could be affinity-purified with avidin-agarose beads, demonstrating that the biotin itself had not been oxidised and was accessible (Fig.  S18) . Although the ESI-mass spectrum appears cleaner than that of TAMRA-labelled MCL-1, irradiation times greater than 1 minute resulted in higher conversion to oxidised protein species -of both unmodified and modified MCL-1 (Fig. S20) . Therefore, irradiation times should be kept to a maximum of 1 minute to prevent oxidative damage of the labelled protein, and may need optimisation for specific protein-reagent pairs, sample type and light source. 
Competition with Ac-BID confirms ligand-directed nature of MCL-1 labelling
To confirm that labelling of MCL-1 was indeed mediated by peptide binding, bringing the ruthenium complex into proximity of the amino acid(s) residue to be labelled, competition experiments were undertaken. Initially, the wild-type sequence, Ac-NOXA-B 4, was used as the competitor peptide in these experiments. However, excess Ac-NOXA-B did not completely abrogate labelling, presumably due to the 10-fold lower inhibitory potency of peptide 4 (2068 ± 334 nM, Fig. 2b ) compared with ruthenium(II)-modified peptide 1 (201 ± 14 nM; Fig. 2b ). Therefore, another peptide that binds in the same hydrophobic groove of MCL-1 as NOXA-B, but with a comparable IC50 value to that of 1 (Ac-BID 5, IC50 390 ± 80 nM) 44 was chosen. Increasing concentrations (0-1000 µM) of Ac-BID 5 were added to the reaction mixture prior to irradiation, resulting in decreasing amounts of fluorescently modified protein -with labelling completely abolished using 1000 µM Ac-BID 5 (Fig. 3a) . The concentration of 5 needed to fully suppress labelling may seem high compared to its IC50, but is not unreasonable because the labelling is a kinetically controlled, irreversible process, which will therefore depend on labelling time as well as relative affinities of peptide:MCL-1 complexes. The intensity of the fluorescent and Coomassie-stained bands was quantified using ImageJ software, and the data from three independent repeats were plotted against the concentration of competitor peptide 5, revealing a dosedependent inhibition of labelling ( Fig. 3b) . These data confirm that the photocatalytic labelling of MCL-1 is dependent on a specific binding event between MCL-1 and Ru(II)(bpy)3-NOXA-B 1. 
MS/MS analysis to determine site of labelling on MCL-1
Tandem mass spectrometry was used to identify the amino acid residues on MCL-1 that were modified upon Ru(II)(bpy)3-NOXA-B 1-mediated photolabelling. Minimal RTA 6 (Fig. 4a ) was chosen over fluorescent and biotinylated RTAs 2 and 3, due to the relative simplicity of the chemical structure, avoiding complication of MS/MS spectra due to fragmentation of the label in the mass spectrometer. For the photolabelling experiment, 10 µM RTA 6 was used to maximise conversion to the labelled species. Intact protein mass spectrometry (ESI-MS) of the labelling mixture prior to proteolytic digestion confirmed a high conversion in the labelling reaction, and incorporation of a single RTA label 6 (Fig. 4b) , consistent with reactions with other RTAs 2 and 3 described above.
Limited proteolysis of MCL-1 before and after modification with RTA 6, using trypsin and Glu-C, resulted in peptide fragments that were analysed using reverse-phase HPLC and Q-TOF MS/MS ( Fig. S21-S22 ; sequence coverage: 97% for unmodified MCL-1 and 94% for modified MCL-1). Peptide mapping analysis identified Cys286 as the only significant site on MCL-1 modified with label 6 (Fig.  4c, Fig. S23 ), despite the presence of two tyrosine residues in the MCL-1 protein sequence (Tyr175 and Tyr185). 
MCL-1 is selectively labelled over BCL-xL in a mixture of proteins
Finally, we determined whether Ru(II)(bpy)3-modified peptide 1 could selectively label MCL-1 over a structurally related BCL-2 family member to which 1 does not bind. 44 According to fluorescence anisotropy experiments, Ru(II)(bpy)3-NOXA-B 1 does not inhibit the interaction of BCL-xL (1-198, Δ27-82) 44 with the fluorescently labelled peptide FITC-BID 7 (in comparison to an IC50 value of 201 ± 14 nM obtained for the MCL-1/FITC-NOXA-B interaction; Fig. 5a ). Therefore, we evaluated the selectivity of ligand-directed photolabelling with 1 between MCL-1 and BCL-xL. Indeed, in an equimolar mixture of MCL-1 and BCL-xL, MCL-1 was labelled selectively over BCL-xL (lane 1, Fig. 5b) . The experiments suggests that a trace amount of BCL-xL can be labelled, but only when MCL-1 is present as well (compare lanes 1 and 5, Fig. 5b ). This observation is not completely understood, but there is tentative evidence for an interaction between MCL-1 and BCL-xL. 51 Higher concentrations of TAMRA label 2 (500 µM) led to more non-specific labelling of BCL-xL (Fig. S13) , which is consistent with the ability of TAMRA itself to act as photocatalyst.
45,46 MCL-1 was also selectively labelled in a stoichiometric mixture of MCL-1 and hDM2, a regulator of the p53 tumour suppressor (Fig. S14) . These results suggest a ligand-directed mode of labelling, i.e. binding of Ru(II)(bpy)3-NOXA-B to MCL-1 facilitates selective labelling of MCL-1 over proteins it does not bind to. 
Discussion
We have demonstrated the use of the peptide-based protein mimic Ru(II)(bpy)3-NOXA-B 1 as an LDL reagent for the selective photocatalytic, ligand-directed labelling of the anti-apoptotic BCL-2 protein, MCL-1. SET photolabelling of recombinant MCL-1 with three different dimethylaniline derivatives was achieved, with irradiation times of 1 min, and relative quantification of labelling was achieved using in-gel fluorescence measurements and ESI-MS analysis. This work builds on previous literature describing the use of small molecule-based Ru(II)(bpy)3-based LDL reagents for the labelling of the enzymes CAII, EGFR and DHFR, [32] [33] [34] and demonstrates the catalytic potential of the SET-based LDL technology as well as the suitability of peptide-based LDL reagents for application on interfaces of PPIs. The selective modification of MCL-1 over BCL-xL and hDM2, and the inhibition of MCL-1 labelling by the addition of competitor peptide Ac-BID 5, suggest a ligand-directed mode of labelling. It should be noted that, due to the conserved sequence homology between BCL-2 family members, this network of PPIs presents a significant challenge for selective protein labelling.
Tandem MS experiments revealed that the predominant labelling site of MCL-1 with minimal dimethylaniline label 6 was a single cysteine residue (Cys286), an amino acid not previously reported to react via this type of LDL chemistry. 36 Kodadek and co-workers reported that protein-protein crosslinking using Ru(II)(bpy)3 reagents can be inhibited by the addition of excess cysteine (or tyrosine, tryptophan, methionine or histidine), 30 suggesting that thiols can trap or quench radicals formed upon photoexcitation. More importantly, Ru(II)(bpy)3 and related complexes have been used for the formation of thiol radicals and their use in C-S bond formation, including on peptides. [52] [53] [54] In addition, the group of Finn demonstrated the use of Ru(II)(bpy)3-mediated photolabelling of Tyr residues of viral capsid proteins with thiol derivatives, 55 suggesting that thiols can efficiently form C-S bonds with electron-rich aromatics in these types of reactions. It should be noted that the distance limits of SETmediated protein labelling (and therefore residue selectivity) may depend on the contribution of different reaction pathways, which in turn may depend on the type of RTA used. 35 We found that the addition of APS as a co-oxidant was necessary for efficient protein labelling in vitro. However, previous literature describing intracellular protein labelling in the absence of APS proposes an alternative pathway whereby molecular oxygen acts as the electron acceptor and labelling is mediated by Ru(III) (which can be stabilised by consumption of superoxide, for example by addition of superoxide dismutase).
30,32 Therefore, future studies will focus on the development of Ru(II)(bpy)3-based LDL to study PPIs in cells and/or cell lysates, which may ultimately enable identification of novel transient/weak PPIs, without the need of protein overexpression. Chemical labelling approaches to study PPIs complement enzyme-mediated proximity labelling approaches such as BioID 56 and APEX. 57 In comparison to traditional chemical crosslinking methods to study PPIs, photolabelling of proteins mediated by Ru(II)(bpy)3-modified peptides such as 1 presents a number of potential advantages. Compared with non-specific reagents such as DSSO, SDA and Sulfo-SBED, ligand-directed labelling of a protein of interest within a complex mixture may facilitate analysis of its individual interactome. Additionally, reagent 1 is unreactive in biological media, activated only upon irradiation at a specific time point, whereas electrophilic groups such as NHS esters or maleimides are susceptible to hydrolysis/reaction with bulk nucleophiles in biological environments. The sub-stoichiometric quantities of Ru(II)(bpy)3 peptide required for efficient labelling and short irradiation times (1 min) at longer wavelengths than UV-activated crosslinking reagents are also less likely to perturb the system under study. Based on reports by Kodadek et al. 30 and on our recent experience with bespoke LED-based irradiation systems for photoaffinity labelling, 58 we expect that labelling with shorter irradiation times can be achieved in future studies. This would allow future dynamic interactome studies with high temporal resolution.
Methods
Synthesis and characterisation. Full synthetic procedures are available in the Supplementary Methods.
Fluorescence anisotropy. Assays were carried out in 384 well Optiplates and wells were read using a Perkin Elmer EnVision™ 2103 MultiLabel plate reader. Fluorescein-labelled peptides were examined using excitation and emission wavelengths of 480 nm and 535 nm, respectively (dichroic mirror 505 nm). All assays were performed in Tris buffer (50 mM Tris, 150 mM NaCl, 0.01% Triton X-100, pH 7.4). Direct titrations and competition assays were performed with minor modifications to those described previously, 44 and are detailed in full in the ESI.
General procedure for photolabelling of recombinant MCL-1. To a solution of MCL-1 (final concentration 5 μM) in ammonium acetate buffer (50 mM, pH 7.5) was added Ru(II)(bpy)3-NOXA-B (final concentration 1 μM), RTA (final concentration 5-10 μM) and APS (final concentration 10 μM), and the mixture was incubated at r.t. for 5 min. The mixture was irradiated for 1 min at r.t., 5 cm from the light source (Kessil H150W-BLUE LED, 32W, 2 × lamps) and then immediately quenched by the addition of DTT (final concentration 10 mM) and analysed using ESI-MS and/or SDS-PAGE. Fluorescently modified peptides were analysed using a Molecular Imager ChemiDoc XRS System (BioRad, CA). The details of specific labelling experiments are provided in the ESI.
MS/MS identification of modified amino acid residue.
To a solution of MCL-1 (50 μM) in ammonium acetate buffer (50 mM, pH 7.5) was added Ru(II)(bpy)3-NOXA-B 1 (final concentration 10 μM), RTA 6 (final concentration 10 μM) and APS (final concentration 10 μM) and the mixture was incubated at r.t. for 5 min. The mixture was irradiated for 1 min at r.t., 5 cm from light source (Kessil H150W-BLUE LED, 32W, 2 × lamps) and immediately quenched by the addition of DTT (final concentration 10 mM). The sample was split into two 50 µL aliquots. To each aliquot, a protease solution (Trypsin or Glu-C; Promega (Madison, WI); 20 ng µL -1 in 25 mM ammonium bicarbonate) was added in a 1:50 ratio (protease:total protein content). Samples were incubated at 37 ºC with shaking for 18 h. The digest reaction was stopped by adding 5 µL of 1% HCOOH, then subjected to purification using a Sep-pak 18 column. The Sep-pak column was equilibrated with 1 mL 0.1% TFA. 500 µL of 0.1% TFA was added to the peptide digest, the mixture was passed through the column and the column was washed with 1 mL 0.1% TFA. Peptides were eluted from the column with 500 µL MeCN-H2O 1:1 + 0.1% HCOOH. The eluant was dried by vacuum centrifugation and the peptides were reconstituted in 20 µL 0.1% TFA. LC separation of the peptide mixtures was performed on an ACQUITY M-Class UPLC (Waters UK, Manchester). 1 µL sample was loaded onto a Symmetry C18 trap column and washed with 1% MeCN/0.1% HCOOH for 5 min at 5 µL min -1 , then the peptides were separated on a HSS T3 C18 analytical column (Waters UK, Manchester) by gradient elution of 1-60% solvent B (0.1% HCOOH in MeCN) in A (0.1% HCOOH in H2O) over 30 min at 0.3 µL min -1 . The peptides were analysed using a Xevo G2-XS Q-TOF mass spectrometer. Data processing was performed using the MassLynX v4.1 suite of software. Peptide MS/MS data from both trypsin and Glu-C digests were processed with PEAKS Studio (Bioinformatics Solutions Inc., Waterloo, Ontario, Canada) and searched against the amino acid sequence. 176.0951 Da was set as a variable modification on any residues to determine the position of the RTA 6 modification. MS mass tolerance was 10 ppm, and fragment ion mass tolerance was 0.05 Da. The false discovery rate was set to 1%. Fourier-transform infrared absorption spectroscopy (IR) was performed on Bruker Platinum-ATR system equipped with an Alpha FT-IR spectrometer. Maximum absorbances are reported for significant bands in cm -1 .
Synthesis of Ru(II)(bpy)3 complex for peptide capping
Scheme S1: Synthetic route to heteroleptic ruthenium(II) bipyridine complex 12 (prepared according to the previously reported method by Meyer et al.) 2
Tris(2,2'-bipyridine)ruthenium(II) dichloride 10
3
To a solution of ruthenium(III) chloride hydrate (500 mg, 2.41 mmol) in DMF (7.5 mL) was added lithium chloride (717 mg, 16.90 mmol), followed by 2,2'-bipyridine (753 mg, 4.82 mmol)
in three equal portions, and the reaction mixture was heated at reflux overnight. The reaction mixture was cooled to room temperature, acetone was added (40 mL) and the mixture was left at -4°C overnight. The brown microcrystals were filtered, washed with Et2O (30 mL) and water (10 mL) to afford a brown solid (1.15 g, 98% 
Bis-(2,2'-bipyridine)-(4'-methyl-[2,2'-bipyridine]-4-carboxylic acid)ruthenium (II) bis-(hexafluorophosphate) 12
2 To a solution of crude 10 (905 mg, 1.87 mmol) in a mixture of EtOH (42 mL) and water (18 mL), was added 4-methyl-2,2'-bipyridine-4'-carboxylic acid (250 mg, 1.17 mmol), and the reaction mixture was heated at reflux for 24 hours. The reaction mixture was cooled to room temperature, the solvents were removed in vacuo and the residue was re-suspended in water (30 mL) and filtered. 
Synthesis of NOXA-B peptides
General comments
All amino acids and resins were purchased from either Novabiochem (Merck) or Sigma- wash with DMF (4 × 4 mL); drain; add amino acid (2.5 mL); add coupling reagent (1 mL); add base (0.5 mL); microwave method (1 min); wash through manifold to waste (2 mL); drain. For the deprotection and coupling of methods that did not use microwave assistance, the reactions were performed by agitation of the resin at r.t. for 10 min and 90 min, respectively. After the final residue, the resin was ejected from the reaction vessel and cleavage and deprotection was performed manually using methods A to D (section 5.
3.2.3).
Methods for manual solid phase N-terminal chain elongation and capping
Method A: Deprotection of N-Fmoc protecting groups
N-terminal Fmoc protecting groups were removed by the addition of 20% piperidine: DMF (5 × 2 mL × 2 min), followed by rinsing the resin with DMF (5 × 2 mL × 2 min). Successful deprotection was determined by a positive colour test (Method B).
Method B: Kaiser Test
The Kaiser Test was used to determine successful coupling or deprotection of manually coupled residues. A few beads of resin were placed in a vial, two drops of each solution (1-3, see below) was added to the beads and the solution was heated to ca. 100 °C for 1 minute.
Successful coupling was indicated by no change in colour of the beads, whereas successful deprotection was indicated by bright blue beads.
Method C: N-terminal acetylation
Acetic anhydride (10 equiv.) and DIPEA (10 equiv.) were dissolved in DMF (1 mL) and the solution was transferred to the resin. After 2 h, the resin was drained, washed with DMF (3 × 2 mL × 2 min) and successful capping determined by a negative colour test (Method B).
Method D: Cleavage and deprotection of Rink amide MBHA resin
After elongation and N-terminal capping was complete, the resin was washed with DMF (5 × 2 mL × 2 min), CH2Cl2 (5 × 2 mL × 2 min), Et2O (5 × 2 mL × 2 min) and dried under vacuum for 1 h. Peptides were simultaneously cleaved and side-chain deprotected using 'Reagent K' TFA:EDT:thioanisole:phenol:H2O, 82:3:5:5:5 (1 × 2 mL × 2 h). The solution was precipitated in ice-cold Et2O (50 mL), placed in a centrifuge (3000 rpm × 1 min) and the supernatant was removed. The precipitate was washed with ice-cold Et2O (3 × 30 mL) and the washed precipitate was dried under a stream of nitrogen (1 h), before being dissolved in H2O and lyophilised.
Peptide purification
Peptides were purified by preparative mass-directed HPLC using a Jupiter Proteo C18
preparative column on an increasing gradient of acetonitrile in water + 0.1% HCOOH (v/v) at a flow rate of 10 mL min 
Tert-butyl(6-((4-(dimethylamino)phenyl)amino)-6-oxohexyl)carbamate 17
To a solution of Boc-Ahx-OH (500 mg, 2.16 mmol) in THF (8 mL 
6-amino-N-(4-(dimethylamino)phenyl)hexanamide 18
To a solution of 17 (1 g, 2.87 mmol) in CH2Cl2 (10 mL) was added trifluoroacetic acid (10 mL) and the reaction mixture was stirred at ambient temperature for 1. 
2-(6-(dimethylamino)-3-(dimethyliminio)-3H-xanthen-9-yl)-5-((6-((4-dimethylamino) phenyl)amino)-6-oxohexyl)carbamoyl)benzoate (TAMRA-RTA) 2
To a solution of amine 18 (50 mg, 0.20 mmol) in DMF (1 mL) was added TAMRA-NHS (138 mg, 0.26 mmol) and NEt3 (56 µL, 0.40 mmol) and the mixture was stirred at ambient temperature for 20 hours. The solvent was removed in vacuo and the residue was re-dissolved in CHCl3 (5 mL). The organic layer was washed with water (1 × 2 mL), saturated aqueous NaHCO3 (aq., 3 × 2 mL), brine (1 × 2 mL), dried over anhydrous Na2SO4, filtered and concentrated to give a purple solid. The crude product was purified by FCC (SiO2, eluting with 
N-(4-(dimethylamino)phenyl)-6-(5-((4S)-2-oxohexahydro-1H-thienol[3,4-d]imidazol-4-
yl)pentanamido)hexanamide (biotin-RTA) 3
To a solution of D-biotin (421 mg, 1.72 mmol) in CHCl3 (20 mL) was added EDCI (331 mg, were washed with water (1 × 5 mL), dried over anhydrous Na2SO4, filtered and concentrated
Expression and purification of MCL-1, BCL-xL and hDM2
Expression and purification of MCL-1, BCL-xL and hDM2 protein was performed as previously described.
5,7,8
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
A resolving gel of appropriate percentage was prepared according to Error! Reference source not found.12% gels were used in analysis of MCL-1 expression and purification, 15% gels were used in the analysis of all photolabelling reactions. Following addition of tetramethylethylenediamine (TEMED), the solution was thoroughly mixed and immediately added to the BioRad tetragel apparatus. A layer of propan-2-ol (1 mL) was applied to the top of the gel. When the resolving gel had set, the propan-2-ol was removed and a stacking gel was prepared according to Table S3 . Once the TEMED was added the solution was thoroughly mixed, immediately added to the top of the resolving gel and comb with a suitable number of lanes was inserted into the stacking gel. Once set, the gel was placed inside an electrophoresis tank and SDS running buffer was (v/v) acetic acid), or alternatively using Instant Blue (TripleRed).
Fluorescence anisotropy assays
General remarks
Fluorescence anisotropy assays were run in 384 well Optiplates and scanned using a Perkin
Elmer EnVision™ 2103 MultiLabel plate reader. Fluorescein labelled peptides used an excitation and emission wavelength of 480 nm (30 nm bandwidth) and 535 nm (40 nm bandwidth) respectively. All assays were run in Tris buffer (50 mM Tris, 150 mM NaCl, 0.01%
Triton X-100, pH 7.4) with additives where described.
Direct binding assays
Processing of fluorescence anisotropy data
The data obtained for both the P (perpendicular intensity) and S (parallel intensity) channels were corrected by subtracting the corresponding control wells, and the resulting values were used to calculate intensity (Eq. 1) and anisotropy (Eq. 2) for each well (using Microsoft Excel).
These data were transferred into OriginPro 8.5, where a plot of anisotropy against protein concentration was fitted using a logistic model (Eq. 3) to obtain the minimum (rmin) and maximum (rmax) values of anisotropy. These values were used to determine the fraction of labelled peptide bound to the protein (fraction ligand bound, Lb, Eq. 4), and fitted (Eq. 5) in OriginPro 8.5 to determine the dissociation constant, Kd.
= 2 +
Where I is the total intensity, G is an instrument factor which was set to 1, and r is the anisotropy.
Where x0 is the midpoint, p is the power and λ is the ratio of Ibound/Iunbound and is equal to 1.
Where Lb is the fraction ligand bound, [FL] is the concentration of fluorescent ligand, y is
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Figure S6: Direct titration of MCL-1 into FITC-NOXA-B to give a Kd of 11 ± 3 nM (error stated is SEM) that corresponds to that described previously (13 ± 2 nM).
9 Error bars represent the standard deviation of three replicates.
BCL-XL/FITC-BID direct titration
Titration of BCL-XL into FITC-BID was performed in a 384 well plate in Tris Buffer (50 mM, Tris, 150 mM NaCl, 0.01% Triton-X-100, pH 7.4) + 0.02 mg/mL BSA with the concentration of BCL-XL starting from 10 µM, diluted over 24 points in a 1/2 regime with [FITC-BID] fixed at 25 nM.
Plates were read after 1 hour incubation and 20 hours incubation, data shown is from 1 hour incubation (assay died at 20 hour time point). Assays were run in triplicate (both test wells and control wells).
Figure S7: Direct titration of BCL-XL into a constant concentration of FITC-BID to give a Kd of 54 ± 8 nM (error stated is SEM) that corresponds to that described previously (79 ± 6 nM).
5
Error bars represent the standard deviation of three replicates.
Competition assays
General remarks
All competition assays were performed in 384 well plates with the concentration of peptide competitor serially diluted over 16 or 24 points in a 1/2 regime with [tracer] fixed at 25 nM. The assays consisted of three test rows (containing protein, tracer and competitor), and three control rows (tracer peptide was replaced with buffer). The intensity, I, and anisotropy, r, were calculated using equations 1 and 2, respectively. A plot of anisotropy against competitor concentration was plotted in OriginPro 8.5 and fitted using Eq. 4 to determine an IC50 value. 
Ligand-directed photolabelling experiments
